HSBC HOLDINGS PLC - JUNO THERAPEUTICS INC ownership

JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 163 filers reported holding JUNO THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 2.35 and the average weighting 1.3%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of JUNO THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$211,000
-3.7%
4,703
-36.0%
0.00%
Q2 2017$219,000
-43.1%
7,343
-57.7%
0.00%
-100.0%
Q1 2017$385,000
-2.3%
17,365
-16.9%
0.00%0.0%
Q4 2016$394,000
+73.6%
20,905
+175.9%
0.00%0.0%
Q3 2016$227,000
-2.6%
7,577
+24.9%
0.00%0.0%
Q2 2016$233,000
-93.0%
6,068
-93.0%
0.00%
-88.9%
Q1 2016$3,317,000
-15.1%
87,089
-2.0%
0.01%0.0%
Q4 2015$3,905,000
+5.4%
88,830
-2.5%
0.01%0.0%
Q3 2015$3,706,000
-21.4%
91,070
+3.0%
0.01%
-10.0%
Q2 2015$4,714,00088,4040.01%
Other shareholders
JUNO THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Crestline Management, LP 25,948,799$1,055,857,000100.00%
Omega Fund Management, LLC 1,329,512$54,098,00030.46%
SOUND ENERGY PARTNERS, INC. 25,800$1,050,0002.12%
Graticule Asia Macro Advisors LLC 435,205$17,708,0002.06%
BB BIOTECH AG 1,305,000$53,100,0001.68%
Kazazian Asset Management, LLC 13,376$544,0000.69%
Rock Springs Capital Management LP 197,001$8,016,0000.65%
TURNER INVESTMENTS LLC 69,680$2,835,0000.57%
MIZUHO SECURITIES USA LLC 49,600$2,018,0000.52%
Private Capital Advisors, Inc. 27,900$1,135,0000.48%
View complete list of JUNO THERAPEUTICS INC shareholders